# Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/ III Colorectal Cancer

> **NCT07095309** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Metanoic Health Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Stage II/III Colon Cancer
- Bowel Cancer

## Interventions

- **DRUG:** Artesunate
- **DRUG:** Artesunate matching Placebo

## Key facts

- **NCT ID:** NCT07095309
- **Lead sponsor:** Metanoic Health Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-15
- **Primary completion:** 2032-08-30
- **Final completion:** 2033-07-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07095309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07095309, "Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/ III Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07095309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*